Postnatal growth retardation is associated with deteriorated intestinal mucosal barrier function using a porcine model

J Cell Physiol. 2021 Apr;236(4):2631-2648. doi: 10.1002/jcp.30028. Epub 2020 Aug 27.

Abstract

Individuals with postnatal growth retardation (PGR) are prone to developing chronic diseases. Abnormal development in small intestine is casually implicated in impaired growth. However, the exact mechanism is still implausible. In this present study, PGR piglets (aged 42 days) were employed as a good model to analyze developmental changes in intestinal mucosal barrier function. Our data demonstrated that PGR piglets exhibited impaired jejunal and ileal epithelial villous morphology and permeability, accompanied by decreased cell proliferation ability and increased apoptosis rate. In addition, the expression of tight junction proteins (ZO-1, claudin 1, and occludin) and E-cadherin was markedly inhibited by PGR. The expression of P-glycoprotein was significantly reduced in PGR piglets, as well as decreased activity of lysozyme. Moreover, the mRNA abundance and content of inflammatory cytokines were significantly increased in the intestinal mucosa and plasma of PGR piglets, respectively. PGR also contributed to lower level of sIgA, and higher level of CD68-positive rate, β-defensins, and protein expression involved p38 MAPK/NF-κB pathway. Furthermore, PGR altered the intestinal microbial community such as decreased genus Alloprevotella and Oscillospira abundances, and led to lower microbial-derived butyrate production, which may be potential targets for treatment. Collectively, our findings indicated that the intestinal mucosal barrier function of PGR piglets could develop the nutritional intervention strategies in prevention and treatment of the intestinal mucosal barrier dysfunction in piglets and humans.

Keywords: chemical barrier; inflammatory response; intestinal morphology; microbial community; postnatal growth retardation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Animals
  • Animals, Newborn
  • Apoptosis
  • Bacteria / metabolism
  • Butyrates / metabolism
  • Cell Proliferation
  • Cytokines / metabolism
  • Disease Models, Animal
  • Gastrointestinal Microbiome
  • Growth Disorders / metabolism*
  • Growth Disorders / microbiology
  • Growth Disorders / pathology
  • Growth Disorders / physiopathology
  • Inflammation Mediators / metabolism
  • Intestinal Mucosa / growth & development
  • Intestinal Mucosa / metabolism*
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / ultrastructure
  • Intestine, Small / growth & development
  • Intestine, Small / metabolism*
  • Intestine, Small / microbiology
  • Intestine, Small / ultrastructure
  • Muramidase / metabolism
  • NF-kappa B / metabolism
  • Permeability
  • Sus scrofa
  • Tight Junction Proteins / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Butyrates
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Tight Junction Proteins
  • p38 Mitogen-Activated Protein Kinases
  • Muramidase